Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377029111> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4377029111 abstract "<b>Abstract ID 53201</b> <b>Poster Board 111</b> <b>Abstract</b> <b>i. Background:</b> Alzheimer’s disease (AD) is a commonest neurodegenerative and dementing disease caused by accumulation of phosphorylated Tau (pTau) and amyloid-beta (Aβ) in brain. Effective strategies to remove Aβ in AD-patient brains have been developed but have limited effects to effectively improve cognitive functions in clinical trials. Differentiated neurons from patient-induced pluripotent stem cells (iPSCs) provide an effective drug discovery model compared to traditional AD models. We therefore used drug repurposing approach and performed high throughput screening with Food and Drug Administration (FDA)-approved drugs to identify novel drugs showing reduced pTau levels in iPSC derived neurons from AD patients. <b>i. Method:</b> We selected two AD patient derived iPSC cell lines having mutated APP and differentiated them to neurons using well-established protocols. We used pTau231/total Tau ratio as readout as pTau231 is an early marker of AD pathology and also related with cognitive decline. To identify compounds that reduce pTau231 accumulation in these Familial AD (FAD) neurons, we screened a collection of 960 FDA approved drugs for their efficacy to lower neuronal pTau231 levels by performing multiplex-ELISA. <b>i. Results</b>: We successfully differentiated patients’ iPSC to neuronal progenitor cells (NPC) followed by mature neurons as evident by western blotting and microscopy results using neuron specific markers. Apparently, in our primary screening 59/960 (6.1%) and 69/960 (7.2%) compounds showed significantly reduced pTau231/total Tau by a Z score <-5 in both the patient-derived iPSC lines respectively. From both of the primary screening, we identified 41 common hits and classified them in to various drug groups. As expected, our classification showed most of the drugs were antimicrobial and anti-cancer drugs. Interestingly, we did identify several drugs for cardiovascular diseases (i.e., gemfibrozil), immune modulators and various other pathologies reducing pTau231/total Tau. In addition, we identified potential mechanism-of-action of hit drugs in AD after RNA-sequencing analysis of drug-treated iPSC-derived neurons. <b>i. Conclusion / future perspectives:</b> Here, we successfully utilized AD-patient iPSC-derived neurons for phenotypic drug screen to identify FDA approved drugs that reduce pathological pTau accumulation in FAD neurons, offering potential treatment for AD." @default.
- W4377029111 created "2023-05-19" @default.
- W4377029111 creator A5021122269 @default.
- W4377029111 creator A5056882784 @default.
- W4377029111 creator A5064155814 @default.
- W4377029111 date "2023-05-18" @default.
- W4377029111 modified "2023-09-29" @default.
- W4377029111 title "Patient iPSC-based high throughput drug screening identifies drug candidates involved in reduced tauopathy associated with Alzheimer's disease" @default.
- W4377029111 doi "https://doi.org/10.1124/jpet.122.532010" @default.
- W4377029111 hasPublicationYear "2023" @default.
- W4377029111 type Work @default.
- W4377029111 citedByCount "0" @default.
- W4377029111 crossrefType "proceedings-article" @default.
- W4377029111 hasAuthorship W4377029111A5021122269 @default.
- W4377029111 hasAuthorship W4377029111A5056882784 @default.
- W4377029111 hasAuthorship W4377029111A5064155814 @default.
- W4377029111 hasBestOaLocation W43770291111 @default.
- W4377029111 hasConcept C103637391 @default.
- W4377029111 hasConcept C104317684 @default.
- W4377029111 hasConcept C107459253 @default.
- W4377029111 hasConcept C126322002 @default.
- W4377029111 hasConcept C145103041 @default.
- W4377029111 hasConcept C169760540 @default.
- W4377029111 hasConcept C2776925932 @default.
- W4377029111 hasConcept C2777739294 @default.
- W4377029111 hasConcept C2779134260 @default.
- W4377029111 hasConcept C2780035454 @default.
- W4377029111 hasConcept C502032728 @default.
- W4377029111 hasConcept C55493867 @default.
- W4377029111 hasConcept C60644358 @default.
- W4377029111 hasConcept C71924100 @default.
- W4377029111 hasConcept C74187038 @default.
- W4377029111 hasConcept C86803240 @default.
- W4377029111 hasConcept C98274493 @default.
- W4377029111 hasConceptScore W4377029111C103637391 @default.
- W4377029111 hasConceptScore W4377029111C104317684 @default.
- W4377029111 hasConceptScore W4377029111C107459253 @default.
- W4377029111 hasConceptScore W4377029111C126322002 @default.
- W4377029111 hasConceptScore W4377029111C145103041 @default.
- W4377029111 hasConceptScore W4377029111C169760540 @default.
- W4377029111 hasConceptScore W4377029111C2776925932 @default.
- W4377029111 hasConceptScore W4377029111C2777739294 @default.
- W4377029111 hasConceptScore W4377029111C2779134260 @default.
- W4377029111 hasConceptScore W4377029111C2780035454 @default.
- W4377029111 hasConceptScore W4377029111C502032728 @default.
- W4377029111 hasConceptScore W4377029111C55493867 @default.
- W4377029111 hasConceptScore W4377029111C60644358 @default.
- W4377029111 hasConceptScore W4377029111C71924100 @default.
- W4377029111 hasConceptScore W4377029111C74187038 @default.
- W4377029111 hasConceptScore W4377029111C86803240 @default.
- W4377029111 hasConceptScore W4377029111C98274493 @default.
- W4377029111 hasLocation W43770291111 @default.
- W4377029111 hasOpenAccess W4377029111 @default.
- W4377029111 hasPrimaryLocation W43770291111 @default.
- W4377029111 hasRelatedWork W2027195009 @default.
- W4377029111 hasRelatedWork W2079253223 @default.
- W4377029111 hasRelatedWork W2299074827 @default.
- W4377029111 hasRelatedWork W2561827752 @default.
- W4377029111 hasRelatedWork W2989777174 @default.
- W4377029111 hasRelatedWork W3044296243 @default.
- W4377029111 hasRelatedWork W4205715258 @default.
- W4377029111 hasRelatedWork W4210273298 @default.
- W4377029111 hasRelatedWork W4220885170 @default.
- W4377029111 hasRelatedWork W4285506882 @default.
- W4377029111 isParatext "false" @default.
- W4377029111 isRetracted "false" @default.
- W4377029111 workType "article" @default.